Association of polymorphisms of NOD2, TLR4 and CD14 genes with susceptibility to gastric mucosa-associated lymphoid tissue lymphoma

Anticancer Research

Volumn 28, Issue 6 A, 2008, Pages 3697-3700

  Türe Özdemir, Filiz ^a   Gazouli, Maria ^b   Tzivras, Michalis ^b   Panagos, Charalambos ^b   Bovaretos, Nikolaos ^b   Petraki, Kalliopi ^c   Giannakopoulos, Athanassios ^d   Korkolopoulou, Penelope ^b   Mantzaris, Gerassimos J ^e,f  

^a MARMARA UNIVERSITY   (Turkey)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c METROPOLITAN HOSPITAL   (Greece)

^d General Hospital   (Nigeria)

^e EVANGELISMOS HOSPITAL   (Greece)

^f NONE   (Greece)

Author keywords

CD14; Gene polymorphism; Helicobacter pylori infection; MALT lymphoma; NOD2; TLR4

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; CD14 ANTIGEN; GENOMIC DNA; TOLL LIKE RECEPTOR 4;

ADULT; AGED; ALLELE; ARTICLE; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; GENE INSERTION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HELICOBACTER INFECTION; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; STOMACH CARCINOGENESIS; STOMACH LYMPHOMA; STOMACH MUCOSA;

ADULT; AGED; ANTIGENS, CD14; GASTRIC MUCOSA; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LYMPHOMA, B-CELL, MARGINAL ZONE; MIDDLE AGED; NOD2 SIGNALING ADAPTOR PROTEIN; POLYMORPHISM, GENETIC; STOMACH NEOPLASMS; TOLL-LIKE RECEPTOR 4;

EID: 58149147611     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Blaser MJ and Atherton JC: Helicobacter pylori persistence: biology and disease. J Clin Invest 113: 321-333, 2004.
2. Lu H, Yamaoka Y and Graham DY: Helicobacter pylori virulence factors: facts and fantasies. Curr Opin Gastroenterol 21: 653-659, 2005.
3. Hoffmann JA, Kafatos FC, Janeway CA and Ezekowitz RA: Phylogenetic perspectives in innate immunity. Science 284: 1313-1318, 1999.
4. Crabtree JE: Gastric mucosal inflammatory responses to Helicobacter pylori. Aliment Pharmacol Ther 10(Suppl 1): 29-37, 1996.
5. Franchi L, Park JH, Shaw MH, Marina-Garcia N, Chen G, Kim YG and Núñez G: Intracellular NOD-like receptors in innate immunity, infection and disease. Cell Microbiol 10: 1-8, 2008.
6. Philpott DJ, Yamaoka S, Israël A and Sansonetti PJ: Invasive Shigella flexneri activates NF-kappa B through a lipopolysaccharide- dependent innate intracellular response and leads to IL-8 expression in epithelial cells. J Immunol 165: 903-914, 2000.
7. Philpott DJ and Girardin SE: The role of Toll-like receptors and Nod proteins in bacterial infection. Mol Immunol 41: 1099-1108, 2004.
8. Rosenstiel P, Hellmig S, Hampe J, Ott S, Till A, Fischbach W, Sahly H, Lucius R, Fölsch UR, Philpott D and Schreiber S: Influence of polymorphisms in the NOD1/CARD4 and NOD2/CARD15 genes on the clinical outcome of Helicobacter pylori infection. Cell Microbiol 8: 1188-1198, 2006.
9. Lien E, Means TK, Heine H, Yoshimura A, Kusumoto S, Fukase K, Fenton MJ, Oikawa M, Qureshi N, Monks B, Finberg RW, Ingalls RR and Golenbock DT: Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide. J Clin Invest 105: 497-504, 2000.
10. Aderem A and Ulevitch RJ: Toll-like receptors in the induction of the innate immune response. Nature 406: 782-787, 2000.
11. Schmausser B, Andrulis M, Endrich S, Lee SK, Josenhans C, Müller-Hermelink HK and Eck M: Expression and subcellular distribution of toll-like receptors TLR4, TLR5 and TLR9 on the gastric epithelium in Helicobacter pylori infection. Clin Exp Immunol 136: 521-526, 2004.
12. Schmausser B, Andrulis M, Endrich S, Müller-Hermelink HK and Eck M: Toll-like receptors TLR4, TLR5 and TLR9 on gastric carcinoma cells: an implication for interaction with Helicobacter pylori. Int J Med Microbiol 295: 179-185, 2005.
13. Hornef MW, Normark BH, Vandewalle A and Normark S: Intracellular recognition of lipopolysaccharide by toll-like receptor 4 in intestinal epithelial cells. J Exp Med 198: 1225-1235, 2003.
14. Maeda S, Akanuma M, Mitsuno Y, Hirata Y, Ogura K, Yoshida H, Shiratori Y and Omata M: Distinct mechanism of Helicobacter pylori-mediated NF-kappa B activation between gastric cancer cells and monocytic cells. J Biol Chem 276: 44856-44864, 2001.
15. Schwartz DA: The genetics of innate immunity. Chest 121: 62S-68S, 2002.
16. Schmitt C, Humeny A, Becker CM, Brune K and Pahl A: Polymorphisms of TLR4: Rapid genotyping and reduced response to lipopolysaccharide of TLR4 mutant alleles. Clin Chem 48: 1661-1667, 2002.
17. Lorenz E, Mira JP, Frees KL and Schwartz DA: Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock. Arch Intern Med 162: 1028-1032, 2002.
18. Gazouli M, Mantzaris G, Kotsinas A, Zacharatos P, Papalambros E, Archimandritis A, Ikonomopoulos J and Gorgoulis VG: Association between polymorphisms in the Toll-like receptor 4, CD14, and CARD15/NOD2 and inflammatory bowel disease in the Greek population. World J Gastroenterol 11: 681-685, 2005.
19. Kirkland T, Viriyakosol S, Perez-Perez GI and Blaser MJ: Helicobacter pylori lipopolysaccharide can activate 70Z/3 cells via CD14. Infect Immun 65: 604-608, 1997.
20. Hellmig S, Fischbach W, Goebeler-Kolve ME, Fölsch UR, Hampe J and Schreiber S: Association study of a functional Toll-like receptor 4 polymorphism with susceptibility to gastric mucosa-associated lymphoid tissue lymphoma. Leuk Lymphoma 46: 869-872, 2005.
21. Hoshino K, Takeuchi O, Kawai T, Sanjo H, Ogawa T, Takeda Y, Takeda K and Akira S: Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol 162: 3749-3752, 1999.
22. Qureshi ST, Larivière L, Leveque G, Clermont S, Moore KJ, Gros P and Malo D: Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4). J Exp Med 189: 615-625, 1999.
23. Kato I, Canzian F, Plummer M, Franceschi S, van Doom LJ, Vivas J, Lopez G, Lu Y, Gioia-Patricola L, Severson RK, Schwartz AG and Munoz N: Polymorphisms in genes related to bacterial lipopolysaccharide/peptidoglycan signaling and gastric precancerous lesions in a population at high risk for gastric cancer. Dig Dis Sci 52: 254-261, 2007.
24. Wu MS, Cheng TY, Shun CT, Lin MT, Chen LC and Lin JT: Functional polymorphisms of CD14 and toll-like receptor 4 in Taiwanese Chinese with Helicobacter pylori-related gastric malignancies. Hepatogastroenterology 53: 807-810, 2006.
25. Mori N, Sato H, Hayashibara T, Senba M, Geleziunas R, Wada A, Hirayama T and Yamamoto N: Helicobacter pylori induces matrix metalloproteinase-9 through activation of nuclear factor kappaB. Gastroenterology 124: 983-992, 2003.
26. Wu CY, Wang CJ, Tseng CC, Chen HP, Wu MS, Lin JT, Inoue H, and Chen GH: Helicobacter pylori promote gastric cancer cells invasion through a NF-kappaB and COX-2-mediated pathway. World J Gastroenter 11: 3197-3203, 2005.